Serum Amyloid P-Component
"Serum Amyloid P-Component" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.
| Descriptor ID |
D000683
|
| MeSH Number(s) |
D12.776.049.407.875 D12.776.124.050.730 D12.776.395.690
|
| Concept/Terms |
Serum Amyloid P-Component- Serum Amyloid P-Component
- Amyloid P-Component, Serum
- P-Component, Serum Amyloid
- Serum Amyloid P Component
- Amyloid P Component
- P Component, Amyloid
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid P-Component".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid P-Component".
This graph shows the total number of publications written about "Serum Amyloid P-Component" by people in this website by year, and whether "Serum Amyloid P-Component" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 7 | 7 | 14 |
| 2018 | 8 | 1 | 9 |
| 2019 | 6 | 3 | 9 |
| 2020 | 1 | 0 | 1 |
| 2021 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Serum Amyloid P-Component" by people in Profiles.
-
Diagnostic Significance of Serum Galectin-3 in Hospitalized Patients with COVID-19-A Preliminary Study. Biomolecules. 2021 08 01; 11(8).
-
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19. J Med Virol. 2021 Dec; 93(12):6653-6659.
-
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat Commun. 2021 06 07; 12(1):3406.
-
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
-
Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells. 2021 05 12; 10(5).
-
The predictive and diagnostic accuracy of long pentraxin-3 in COVID-19 pneumonia Turk J Med Sci. 2021 04 30; 51(2):448-453.
-
Circulating pentraxin 3 in severe COVID-19 or other pulmonary sepsis. Eur J Clin Invest. 2021 May; 51(5):e13530.
-
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. PLoS One. 2021; 16(1):e0245924.
-
Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol. 2021 01; 22(1):19-24.
-
Pentraxin 3: Potential prognostic role in SARS-CoV-2 patients admitted to the emergency department. J Infect. 2021 04; 82(4):84-123.